30 April 2024
For the fourth year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.
Following on from his ALS Ice Bucket Challenge, Oxford PharmaGenesis Commercial Director Dr Richard White will be taking part in the Oxford to Cambridge bike ride on Saturday 27 September to raise money for the British Heart Foundation. “Unfortunately, cardiovascular disease runs in my family,” said Richard, who took up road cycling last year in…
If anyone has any connection with the world of social media, they will be aware of the viral craze going around … the #icebucketchallenge in aid of the Amyotrophic Lateral Sclerosis Association.
Oxford PharmaGenesis staff gathered at group headquarters in Oxford this week for the company’s annual summer party.
The need for an integrated, multidisciplinary approach to drug development, healthcare policy and decision-making was a recurring theme of the Westminster Business Forum Keynote Seminar on UK health life sciences, attended by Oxford PharmaGenesis this week in Whitehall, London, UK. This strongly supports the HealthScience concept developed by Oxford PharmaGenesis, which combines the clinical and…
A pioneering systematic methodology to identify observational data sources for specific needs has been presented by Oxford PharmaGenesis today at ISPOR’s 19th Annual International Meeting in Montreal, Canada.
A pioneering method to identify and recommend bespoke data sources for global programmes of real-world evidence is being presented at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).
